Chris Viehbacher

Biogen: Don’t expect any big acquisitions this year
BioPharma Dive
Wed, 04/24/24 - 09:31 pm
Biogen
Pharma CEOs
Chris Viehbacher
M&A
Biogen CEO sees progress in launch of Alzheimer’s drug Leqembi
BioPharma Dive
Mon, 01/8/24 - 10:22 pm
Biogen
Pharma CEOs
Chris Viehbacher
Leqembi
Alzheimer's disease
insurance
JPMHC 2024
As Biogen's sales flatline, CEO Chris Viehbacher touts progress on Leqembi, Skyclarys and other launches
Fierce Pharma
Wed, 11/8/23 - 12:10 pm
Biogen
Pharma CEOs
Chris Viehbacher
earnings
Leqembi
Skyclarys
I Was Concerned About Biogen Until I Heard These 11 Words From Its CEO
Motley Fool
Thu, 07/27/23 - 10:17 am
Biogen
Alzheimer's disease
Pharma CEOs
Chris Viehbacher
Biogen isn’t concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
CNBC
Wed, 04/26/23 - 09:59 am
Biogen
earnings
Pharma CEOs
Chris Viehbacher
Eli Lilly
Alzheimer's disease
Leqembi
donanemab
Biogen chairman to step down as new CEO walks thin line with Alzheimer's launch Leqembi
Fierce Pharma
Wed, 02/15/23 - 06:28 pm
Biogen
Chris Viehbacher
Stelios Papadopoulos
Pharma CEOs
Alzheimer's disease
Leqembi
New Biogen CEO tips subcutaneous lecanemab to help expansion into pre-symptomatic Alzheimer’s
Fierce Pharma
Fri, 01/13/23 - 10:59 am
Biogen
Chris Viehbacher
lecanemab
Alzheimer's disease
Pharma CEOs
Biogen appoints ex-Sanofi chief Christopher Viehbacher as CEO
Medical Marketing and Media
Thu, 11/10/22 - 10:51 am
Biogen
Pharma CEOs
Christopher Viehbacher
Chris Viehbacher
Chris Viehbacher leaps back into biotech as head of Swiss billionaire's $2B fund
Fierce Biotech
Tue, 06/23/15 - 10:31 am
biotech
Chris Viehbacher
CEO Pay Row at Sanofi AGM
In-Pharma Technologist
Mon, 05/18/15 - 09:03 am
Sanofi
executive pay
Olivier Brandicourt
Chris Viehbacher
Ex-Sanofi chief Viehbacher makes a $5M-plus severance deal
Fierce Pharma
Fri, 01/23/15 - 08:27 am
Sanofi
Chris Viehbacher
executive pay
Former Sanofi CEO Viehbacher Says Kickback Allegations Baseless
Bloomberg
Fri, 12/5/14 - 08:23 am
Sanofi
Chris Viehbacher
kickbacks
diabetes
whistleblower lawsuits
Biotech's 3 Most Influential CEOs
Motley Fool
Thu, 11/20/14 - 10:54 am
biotech
Ivax
Teva Pharmaceutical
Phillip Frost
OPKO Health
Chris Viehbacher
Sanofi
Gilead Sciences
John C. Martin
Sanofi SA (SNY) Stock On A Decline Since Ousting Of CEO Chris Viehbacher
Bidness Etc.
Mon, 11/10/14 - 11:16 am
Sanofi
Chris Viehbacher
Digesting Sanofi's Two Pieces Of News- Lantus' Challenging Outlook And The CEO Dismissal
Seeking Alpha
Wed, 11/5/14 - 08:11 am
Sanofi
Lantus
Chris Viehbacher
Diabetes Analyst: Sanofi CEO's Firing May Spell Trouble for MannKind Afrezza Partnership
TheStreet.com
Tue, 11/4/14 - 02:23 pm
diabetes
Sanofi
Chris Viehbacher
Chris Viehbacher leaving Sanofi without a U.S.-style windfall
Fierce Biotech
Thu, 10/30/14 - 12:16 pm
Chris Viehbacher
Sanofi
Whither Sanofi? How Easily Can the Drug Maker Find a New CEO?
WSJ Pharmalot
Wed, 10/29/14 - 11:50 am
Sanofi
Pharma CEOs
Chris Viehbacher
Dear Sanofi: Firing CEO Chris Viehbacher Is A Huge Mistake
Forbes
Wed, 10/29/14 - 09:18 am
Sanofi
Chris Viehbacher
Sanofi CEO Christopher Viehbacher Fired Over Solitary Management Style, Chairman Says
WSJ Online
Wed, 10/29/14 - 07:58 am
Sanofi
Pharma CEOs
Chris Viehbacher

Pages